Neogen launches the new Molecular Detection Assay 2 - Quantitative Salmonella (MDA2QSAL96) to deliver consistency and sensitivity with an easy-to-use workflow that saves time and resources.
NEOG's Food Safety business witnesses a slight year-over-year decrease in revenues for the second quarter of fiscal 2025.
Neogen Corporation (NASDAQ:NEOG) Q2 2025 Earnings Conference Call January 10, 2024 8:00 AM ET.
Neogen (NEOG) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.11 per share a year ago.
Besides Wall Street's top -and-bottom-line estimates for Neogen (NEOG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended November 2024.
NEOG faces intense competition due to the development of new technologies by competitors, which could affect the marketability and profitability of its products.
Neogen expands the Petrifilm product line with the introduction of Petrifilm Bacillus cereus Count Plate.
NEOG faces intense competition resulting from competitors' development of new technologies, which could affect the marketability and profitability of its products.
NEOG's Food Safety and Animal Safety businesses witness a year-over-year decrease in revenues in the first quarter of fiscal 2025.
Neogen reported its Q1 earnings, which missed expectations. Weak demand trends across food and animal safety end markets have pressured the sales outlook. We expect shares to remain volatile until there is evidence of a growth rebound.
Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended August 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Neogen Corporation (NASDAQ:NEOG ) Q1 2025 Earnings Conference Call October 10, 2024 8:00 AM ET Company Participants Bill Waelke - Vice President, Investor Relations & Treasury John Adent - Chief Executive Officer Dave Naemura - Chief Financial Officer Conference Call Participants David Westenberg - Piper Sandler Brandon Vazquez - William Blair Thomas DeBourcy - Nephron Research Operator Good morning, ladies and gentlemen, and welcome to the Neogen Corporation First Quarter 2025 Earnings Call. At this time, all lines are in listen-only mode.